FAB-144
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
PubChem (CID) | 102135350 |
ChemSpider | 32055552 |
Chemical and physical data | |
Formula | C20H27FN2O |
Molar mass | 330.4 g/mol |
3D model (Jmol) | Interactive image |
| |
|
FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug.[1] It is the indazole analogue of XLR-11.
Legal status
Sweden's public health agency suggested classifying FAB-144 as hazardous substance on November 10, 2014.[2]
See also
References
- ↑ "FAB-144". Cayman Chemical. Retrieved 23 July 2015.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.
This article is issued from Wikipedia - version of the 6/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.